Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2021

View Archived Issues

RTX-N109D, a rituximab variant with lower sensitivity to CA125 mediated immunosuppression

SRI-42127 attenuates glial activation in a model of LPS-induced neuroinflammation

Gfap-targeted ASO therapy shows efficacy in rat model of Alexander disease

EIDD-2749 shows broad antiviral activity against RSV, SARS-CoV-2 and related RNA viruses

ED to AD: Viagra associated with lower risk of Alzheimer's disease

Jiangsu Protelight Pharmaceutical & Biotechnology patents amino acid derivatives

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

New ACSS2 inhibitors discovered at Metabomed

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Incyte describes new mutant GTPase KRAS inhibitors

Phylex develops SARS-CoV-2 vaccine targeting Delta and Omicron variants

Gritstone and CEPI expand agreement for SAM vaccine to target SARS-CoV-2 Omicron variant

Gb Sciences develops cannabinoid-containing complex mixtures to target CRS in COVID-19

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Spago completes regulatory preclinical program with Tumorad

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Bsense reports preclinical data on BSEN-627 in rat pain model

GreenLight and IAVI partner on mRNA vaccine candidate for SARS-CoV-2 Omicron variant

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...